CBRE Group

CBRE · NYSE

$134.23+$3.46 (+2.65%)TodayMarket closed · Oct 20, 6:30 PM ET

Prev close $130.77

CBRE analyst rating

BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy4
Hold0
Underperform0
Sell0

12-month price target · 15 analysts

Average $185.19 (+38.0% upside)

Low: $146.55
Now: $134.23
High: $210.00

Upgrades and downgrades

The latest rating actions, newest first

CBRE analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Keefe, Bruyette & Woods	Oct 9, 2026	Maintains	Outperform	$174.00 → $164.00	51%
Evercore ISI Group	Sep 28, 2026	Maintains	Outperform	$175.00 → $166.00	45%
Barclays	Aug 17, 2026	Maintains	Overweight	$180.00 → $183.00	32%
UBS	Jul 30, 2026	Maintains	Buy	$185.00 → $190.00	63%
Evercore ISI Group	Jul 30, 2026	Maintains	Outperform	$169.00 → $175.00	45%
Keefe, Bruyette & Woods	Jul 30, 2026	Maintains	Outperform	$158.00 → $174.00	51%
Barclays	Jul 28, 2026	Maintains	Overweight	$178.00 → $180.00	32%
Evercore ISI Group	Jun 30, 2026	Maintains	Outperform	$179.00 → $169.00	45%
Barclays	May 5, 2026	Maintains	Overweight	$175.00 → $178.00	32%
Evercore ISI Group	Apr 24, 2026	Maintains	Outperform	$163.00 → $179.00	45%

The case for and against

Updated Oct 19, 2025

Bull case

CBRE Group is well-positioned to capitalize on the long-term changes in demand for real estate services driven by the institutionalization of commercial real estate (CRE). The ongoing trend of outsourcing and the shift towards more contractual fees are expected to enhance revenue stability and accelerate growth. Additionally, forecasts indicate an increase in earnings per share (EPS) by 2-3% for 2025 to 2027, supported by improved margins in Advisory and Business Operations, highlighting the company’s operational leverage and potential for further margin expansion.

Bear case

The analysis indicates that CBRE Group's stock is currently trading at elevated multiples, specifically 18-21x for 2025-2026 earnings per share and 12.4-13.3x EV/EBITDA, positioning it at the upper end of cyclical recovery valuations despite a decrease from late 2024 peaks. Additionally, the potential risks of a global economic downturn, weakening commercial real estate fundamentals, and reduced capital markets activity present significant challenges to the firm's transaction-focused business model. These factors contribute to a negative outlook as they highlight vulnerabilities in CBRE’s performance metrics amid an uncertain economic climate.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.